0001213900-19-026153.txt : 20191213 0001213900-19-026153.hdr.sgml : 20191213 20191213163105 ACCESSION NUMBER: 0001213900-19-026153 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191212 FILED AS OF DATE: 20191213 DATE AS OF CHANGE: 20191213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHABER CHRISTOPHER J CENTRAL INDEX KEY: 0001068029 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14778 FILM NUMBER: 191284945 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER NAME: FORMER CONFORMED NAME: SCHABER CHRISTOPHER DATE OF NAME CHANGE: 19980811 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 4 1 ownership.xml X0306 4 2019-12-12 0 0000812796 SOLIGENIX, INC. SNGX 0001068029 SCHABER CHRISTOPHER J 29 EMMONS DRIVE, SUITE B-10 PRINCETON NJ 08540 1 1 0 0 Chairman, CEO and President Option (Right to Buy) 1.24 2019-12-12 4 A 0 60000 0 A 2019-12-12 2029-12-11 Common Stock 60000 60000 D The stock option vested immediately as to 15,000 shares and vests as to the remainder at a rate of 3,750 of the shares on each three (3) month anniversary of December 12, 2019. /s/ Christopher J. Schaber 2019-12-13